Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125842142 | 12584214 | 2 | F | 20130618 | 20160801 | 20160722 | 20160805 | EXP | US-GLAXOSMITHKLINE-US2016GSK104909 | GLAXOSMITHKLINE | 63.65 | YR | F | Y | 88.00000 | KG | 20160805 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125842142 | 12584214 | 1 | PS | Bupropion HCl | BUPROPION HYDROCHLORIDE | 1 | 100 MG, QD | 20358 | 100 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
125842142 | 12584214 | 2 | SS | Bupropion HCl | BUPROPION HYDROCHLORIDE | 1 | 20358 | PROLONGED-RELEASE TABLET | |||||||||||
125842142 | 12584214 | 3 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | U | 0 | |||||||||||
125842142 | 12584214 | 4 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
125842142 | 12584214 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, QD | M56716 | 0 | 100 | MG | QD | ||||||
125842142 | 12584214 | 6 | SS | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
125842142 | 12584214 | 7 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
125842142 | 12584214 | 8 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 0 | ||||||||||||
125842142 | 12584214 | 9 | C | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | UNK | 0 | |||||||||||
125842142 | 12584214 | 10 | C | SUMATRIPTAN SUCCINATE. | SUMATRIPTAN SUCCINATE | 1 | 1 OR 2 AS NEEDED, PRN | 0 | TABLET | ||||||||||
125842142 | 12584214 | 11 | C | CLARITIN | LORATADINE | 1 | 10 MG, VA ( EVERY 2 WEEKS) | 0 | 10 | MG | |||||||||
125842142 | 12584214 | 12 | C | CLARITIN | LORATADINE | 1 | 0 | ||||||||||||
125842142 | 12584214 | 13 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
125842142 | 12584214 | 14 | C | BACLOFEN. | BACLOFEN | 1 | 20 MG, TID | 0 | 20 | MG | TID | ||||||||
125842142 | 12584214 | 15 | C | BACLOFEN. | BACLOFEN | 1 | 20 MG, QD | 0 | 20 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125842142 | 12584214 | 1 | Asthenia |
125842142 | 12584214 | 2 | Somnolence |
125842142 | 12584214 | 3 | Disturbance in attention |
125842142 | 12584214 | 4 | Restless legs syndrome |
125842142 | 12584214 | 5 | Fibromyalgia |
125842142 | 12584214 | 6 | Neuralgia |
125842142 | 12584214 | 7 | Crying |
125842142 | 12584214 | 8 | Major depression |
125842142 | 12584214 | 9 | Disturbance in attention |
125842142 | 12584214 | 10 | Migraine |
125842142 | 12584214 | 11 | Multiple allergies |
125842142 | 12584214 | 12 | Asthma |
125842142 | 12584214 | 14 | Muscle spasms |
125842142 | 12584214 | 15 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125842142 | 12584214 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125842142 | 12584214 | Anxiety | |
125842142 | 12584214 | Blood glucose decreased | |
125842142 | 12584214 | Brain injury | |
125842142 | 12584214 | Cognitive disorder | |
125842142 | 12584214 | Drug ineffective | |
125842142 | 12584214 | Dyspnoea | |
125842142 | 12584214 | Eye injury | |
125842142 | 12584214 | Eye irritation | |
125842142 | 12584214 | Fall | |
125842142 | 12584214 | Fibromyalgia | |
125842142 | 12584214 | Foreign body | |
125842142 | 12584214 | Hallucination | |
125842142 | 12584214 | Logorrhoea | |
125842142 | 12584214 | Memory impairment | |
125842142 | 12584214 | Muscle contractions involuntary | |
125842142 | 12584214 | Myalgia | |
125842142 | 12584214 | Neuralgia | |
125842142 | 12584214 | Off label use | |
125842142 | 12584214 | Panic attack | |
125842142 | 12584214 | Pharyngeal oedema | |
125842142 | 12584214 | Post concussion syndrome | |
125842142 | 12584214 | Somnolence | |
125842142 | 12584214 | Suicidal ideation | |
125842142 | 12584214 | Suicide attempt | |
125842142 | 12584214 | Swollen tongue | |
125842142 | 12584214 | Unresponsive to stimuli | |
125842142 | 12584214 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125842142 | 12584214 | 1 | 2009 | 0 | ||
125842142 | 12584214 | 5 | 201505 | 0 | ||
125842142 | 12584214 | 7 | 201001 | 0 | ||
125842142 | 12584214 | 9 | 201406 | 0 | ||
125842142 | 12584214 | 10 | 201409 | 0 | ||
125842142 | 12584214 | 11 | 2008 | 0 | ||
125842142 | 12584214 | 13 | 2011 | 0 | ||
125842142 | 12584214 | 14 | 201411 | 0 |